News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Oculus Innovative Sciences, Inc. (OCLS)' Partner, More Pharma Corporation, Launches Microcyn®-Based Oral And Throat Infection Treatment Product In Mexico


4/22/2014 8:54:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PETALUMA, Calif., April 22, 2014 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 33 countries, today announced the commercialization in Mexico of the first product under the Microdacyn60® Oral Care brand intended for use as an adjunct treatment in both mouth and throat infections. Commercialized under the brand name Microdacyn60™ Bucofaringeo™, it is now available in Mexican pharmacies. At the same time, the More Pharma sales team is introducing the treatment to general practitioners along with ear, nose and throat specialists throughout Mexico.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES